NCT04476888View on ClinicalTrials.gov

Convalescent Plasma Treatment in COVID-19

NACompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

April 26, 2020

Primary Completion Date

September 15, 2020

Study Completion Date

October 10, 2020

Conditions
Covid19
Interventions
BIOLOGICAL

Convalescent Plasma (CP)

500 ml of Convalescent plasma in a single dose will be transfused over a period of 1- 2 hours.

OTHER

Drugs and supportive care

This will include drugs like steroids, tocilizumab, azithromycin and supportive care

Trial Locations (1)

Unknown

Aga Khan University Hospital, Karachi

All Listed Sponsors
lead

Aga Khan University

OTHER

NCT04476888 - Convalescent Plasma Treatment in COVID-19 | Biotech Hunter | Biotech Hunter